Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of May 2025. The report specifically details a transaction in own shares executed under the company's share buyback programme announced on March 28, 2025.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity.
- Shares Purchased: 820,774 ordinary shares
- Purchase Date: May 19, 2025
- Price Range: 403.30p (Low) to 406.40p (High)
- Volume Weighted Average Price: 404.64p
- Post-Transaction Share Capital: 9,011,766,618 ordinary shares
- Treasury Shares: 4,080,205
- Voting Shares: 9,007,686,413
Material Changes
The primary material change is the reduction of outstanding shares due to the cancellation of 820,774 shares purchased on May 19, 2025. This transaction updates the total number of ordinary shares with voting rights to 9,007,686,413.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on financial performance, or discussion of risks and contingencies. It is a routine disclosure of a share buyback transaction in compliance with the Market Abuse Regulation.
Investor Verification Checklist
- Verify the total number of shares purchased under the buyback programme since its inception on March 28, 2025.
- Confirm the remaining authorization limit for the current buyback programme.
- Review the full trade breakdown available via the London Stock Exchange link provided in the filing.
- Check subsequent filings for updates to the treasury share count and voting rights.